{
    "name": "sevelamer",
    "comment": "Rx",
    "other_names": [
        "Renagel",
        "Renvela"
    ],
    "classes": [
        "PO4 Scavengers"
    ],
    "source": "https://reference.medscape.com/drug/renagel-renvela-sevelamer-343208",
    "pregnancy": {
        "common": [
            "Not absorbed systemically following oral administration and maternal use not expected to result in fetal exposure to the drug",
            "May decrease serum levels of fat soluble vitamins and folic acid in pregnant women; consider supplementation"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Not absorbed systemically by mother following oral administration; breastfeeding is not expected to result in exposure of child to drug",
            "May decrease serum levels of fat soluble vitamins and folic acid in pregnant women; consider supplementation"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity",
                "Bowel obstruction"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Caution in dysphagia, GI motility disorders, GI surgery",
                "Cases of bowel obstruction, bleeding gastrointestinal ulcers, colitis, ulceration, necrosis, and perforation reported; inflammatory disorders may resolve upon discontinuation; reevaluate treatment in patients who develop severe gastrointestinal symptoms",
                "Tablets should not be crushed, broken, or chewed (tablets rapidly expand and become a choking hazard)",
                "Dysphagia and esophageal tablet retention reported, in some cases requiring hospitalization and intervention; consider sevelamer oral suspension in patients with history of swallowing disorders",
                "May decrease GI absorption of antiarrhythmic, fat soluble vitamins, folic acid, and antiseizure medications; take medications 1 hour before or 3 hours after sevelamer dose",
                "Monitor serum bicarbonate and chloride levels",
                "Monitor fat soluble vitamin and folic acid levels, especially in pregnancy",
                "Safety/efficacy with dialysis not studied"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Contraindicated",
            "interaction_with": "potassium phosphates, IV",
            "description": {
                "common": "sevelamer decreases effects of potassium phosphates, IV by cation binding in GI tract. Contraindicated. Sevelamer decreases serum phosphate concentration by binding dietary phosphate."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "sodium phosphates, IV",
            "description": {
                "common": "sevelamer decreases effects of sodium phosphates, IV by cation binding in GI tract. Contraindicated. Sevelamer decreases serum phosphate concentration by binding dietary phosphate."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "erdafitinib",
            "description": {
                "common": "sevelamer, erdafitinib. Other (see comment). Avoid or Use Alternate Drug. \nComment: Avoid coadministration during initial dosing adjustment period (ie, first 21 days). Increases in serum phosphate levels are a pharmacodynamic effect of FGFR inhibition. Serum phosphate binders may obscure decisions regarding initial dosage increase."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "acebutolol",
            "description": {
                "common": "sevelamer decreases levels of acebutolol by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "acetazolamide",
            "description": {
                "common": "sevelamer decreases levels of acetazolamide by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "adenosine",
            "description": {
                "common": "sevelamer decreases levels of adenosine by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "amiodarone",
            "description": {
                "common": "sevelamer decreases levels of amiodarone by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "carbamazepine",
            "description": {
                "common": "sevelamer decreases levels of carbamazepine by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ciprofloxacin",
            "description": {
                "common": "sevelamer decreases levels of ciprofloxacin by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Administer oral quinolones at least 1 hour before or 3 hours after sevelamer. ."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "clonazepam",
            "description": {
                "common": "sevelamer decreases levels of clonazepam by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "diazepam",
            "description": {
                "common": "sevelamer decreases levels of diazepam by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dichlorphenamide",
            "description": {
                "common": "dichlorphenamide, sevelamer.\nEither increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Both drugs can cause metabolic acidosis."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "digoxin",
            "description": {
                "common": "sevelamer decreases levels of digoxin by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "disopyramide",
            "description": {
                "common": "sevelamer decreases levels of disopyramide by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "encainide",
            "description": {
                "common": "sevelamer decreases levels of encainide by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "eslicarbazepine acetate",
            "description": {
                "common": "sevelamer decreases levels of eslicarbazepine acetate by increasing elimination. Modify Therapy/Monitor Closely."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "esmolol",
            "description": {
                "common": "sevelamer decreases levels of esmolol by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ethosuximide",
            "description": {
                "common": "sevelamer decreases levels of ethosuximide by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "felbamate",
            "description": {
                "common": "sevelamer decreases levels of felbamate by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "flecainide",
            "description": {
                "common": "sevelamer decreases levels of flecainide by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "fosphenytoin",
            "description": {
                "common": "sevelamer decreases levels of fosphenytoin by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "gabapentin",
            "description": {
                "common": "sevelamer decreases levels of gabapentin by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "gabapentin enacarbil",
            "description": {
                "common": "sevelamer decreases levels of gabapentin enacarbil by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ibutilide",
            "description": {
                "common": "sevelamer decreases levels of ibutilide by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "lacosamide",
            "description": {
                "common": "sevelamer decreases levels of lacosamide by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "lamotrigine",
            "description": {
                "common": "sevelamer decreases levels of lamotrigine by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "levetiracetam",
            "description": {
                "common": "sevelamer decreases levels of levetiracetam by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "lidocaine",
            "description": {
                "common": "sevelamer decreases levels of lidocaine by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "lorazepam",
            "description": {
                "common": "sevelamer decreases levels of lorazepam by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "methsuximide",
            "description": {
                "common": "sevelamer decreases levels of methsuximide by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "mexiletine",
            "description": {
                "common": "sevelamer decreases levels of mexiletine by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "oxcarbazepine",
            "description": {
                "common": "sevelamer decreases levels of oxcarbazepine by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "phenobarbital",
            "description": {
                "common": "sevelamer decreases levels of phenobarbital by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "phenytoin",
            "description": {
                "common": "sevelamer decreases levels of phenytoin by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "primidone",
            "description": {
                "common": "sevelamer decreases levels of primidone by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "procainamide",
            "description": {
                "common": "sevelamer decreases levels of procainamide by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "propafenone",
            "description": {
                "common": "sevelamer decreases levels of propafenone by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "propranolol",
            "description": {
                "common": "sevelamer decreases levels of propranolol by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "quinidine",
            "description": {
                "common": "sevelamer decreases levels of quinidine by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "rufinamide",
            "description": {
                "common": "sevelamer decreases levels of rufinamide by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "sodium sulfate/?magnesium sulfate/potassium chloride",
            "description": {
                "common": "sodium sulfate/?magnesium sulfate/potassium chloride increases toxicity of sevelamer by Other (see comment). Use Caution/Monitor. \nComment: Coadministration with medications that cause fluid and electrolyte abnormalities may increase the risk of adverse events of seizure, arrhythmias, and renal impairment."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "sodium sulfate/potassium sulfate/magnesium sulfate",
            "description": {
                "common": "sodium sulfate/potassium sulfate/magnesium sulfate increases toxicity of sevelamer by Other (see comment). Use Caution/Monitor. \nComment: Coadministration with medications that cause fluid and electrolyte abnormalities may increase the risk of adverse events of seizure, arrhythmias, and renal impairment."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "sotalol",
            "description": {
                "common": "sevelamer decreases levels of sotalol by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "tiagabine",
            "description": {
                "common": "sevelamer decreases levels of tiagabine by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "topiramate",
            "description": {
                "common": "sevelamer decreases levels of topiramate by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "valproic acid",
            "description": {
                "common": "sevelamer decreases levels of valproic acid by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "verapamil",
            "description": {
                "common": "sevelamer decreases levels of verapamil by increasing elimination. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "zonisamide",
            "description": {
                "common": "sevelamer decreases levels of zonisamide by increasing elimination. Use Caution/Monitor."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Vomiting",
            "percent": "22"
        },
        {
            "name": "Nausea",
            "percent": "20"
        },
        {
            "name": "Diarrhea",
            "percent": "19"
        },
        {
            "name": "Dyspepsia",
            "percent": "16"
        },
        {
            "name": "Nasopharyngitis",
            "percent": "14"
        },
        {
            "name": "Limb pain",
            "percent": "13"
        },
        {
            "name": "Pruritus",
            "percent": "13"
        },
        {
            "name": "Arthralgia",
            "percent": "12"
        },
        {
            "name": "Bronchitis",
            "percent": "11"
        },
        {
            "name": "Dyspnea",
            "percent": "10"
        },
        {
            "name": "Hypertension",
            "percent": "10"
        },
        {
            "name": "Abdominal pain",
            "percent": "9"
        },
        {
            "name": "Constipation",
            "percent": "8"
        },
        {
            "name": "Flatulence",
            "percent": "8"
        },
        {
            "name": "Peritonitis",
            "percent": "8"
        },
        {
            "name": "during peritoneal dialysis",
            "percent": "5-7"
        },
        {
            "name": "Hypercalcemia",
            "percent": null
        },
        {
            "name": "Back pain",
            "percent": null
        },
        {
            "name": "Cough",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Pyrexia",
            "percent": null
        },
        {
            "name": "Upper respiratory infection",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "Intestinal perforation",
            "percent": null
        },
        {
            "name": "Fecal impaction",
            "percent": null
        },
        {
            "name": "Intestinal obstruction",
            "percent": null
        },
        {
            "name": "Hypersensitivity",
            "percent": null
        },
        {
            "name": "Bleeding gastrointestinal ulcers",
            "percent": null
        },
        {
            "name": "colitis",
            "percent": null
        },
        {
            "name": "ulceration",
            "percent": null
        },
        {
            "name": "necrosis",
            "percent": null
        }
    ]
}